Search

Search Constraints

You searched for: Author/Creator Levacic, Danijela

Search Results

3. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial. Issue 1 (25th May 2022)